Psilocybin in Solomon Islands: not individually verified
We have not confirmed that Psilocybin specifically is scheduled in Solomon Islands, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. No entry for psilocybin was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98) reprint as in force at 1 October 2009 (text); the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) and the further proclamation LN 6 of 1988 (printed margin note LN 61/1988), read from the page images of printed pages 2821 to 2824 of the 1996 Revised Edition; the Pharmacy and Poisons Act (Cap. 105) reprint as in force at 5 February 2024, including Schedule A and Schedule B (the Poisons List, Parts I and II); the Poisons Rules made under section 61 of that Act, as printed in the 1996 Revised Edition (printed pages 3000 to 3043, margin notes amended to LN 63 of 1988), read from the page images for rules 8 to 13 and 30 to 35, the First Schedule (pages 3013 to 3015), the Third Schedule Group II (page 3017) and every page of the Fourth Schedule of substances sold by retail only on a prescription (pages 3019 to 3042); and the Dangerous Drugs (Methylamphetamine) Rules 2025 (Gazette No. 158, 5 November 2025). Terms searched: psilocybin, psilocin, Psilocybe, mushroom, fungi, fungus, magic mushroom, tryptamine, bufotenine, DMT. Result: no entry for psilocybin, psilocin or any mushroom in the proclamation schedules, the Act, the Poisons List, the Fourth Schedule or the 2025 Rules. The lists searched are quoted here. The proclamation of 21 September 1987 (LN 101 of 1987) reads 'Part III of the Dangerous Drugs Act is applied to the drugs specified in the Schedule hereto', and neither its paragraph 1 list (printed pages 2821 and 2822) nor its paragraph 6 list (printed page 2823) prints psilocybin; LN 6 of 1988 (printed page 2824) applies Part III in the same words and its paragraph (e) list does not print psilocybin; section 13(1) of the Act reads 'The provisions of this Part of this Act shall apply to the following substances' and its paragraphs (a) to (i) do not name psilocybin; Schedule B of the Pharmacy and Poisons Act (headed «THE POISONS LIST», Parts I and II, reprint as in force 5 February 2024) does not print psilocybin; and the Fourth Schedule to the Poisons Rules (1996 Revised Edition, printed pages 3019 to 3042, headed «FOURTH SCHEDULE» and described in its own words as 'Substances required by rule 11 to be sold by retail only on a prescription given by a registered medical practitioner, registered dentist or qualified veterinary surgeon') does not print psilocybin. Under section 13(2) a later proclamation may add substances, so these absences are not a finding about the substance itself. 'Bufotazine' is printed in paragraph 1 of the proclamation (page 2821); no instrument read draws an equivalence between it and psilocybin, so no verdict is given on any route through it. Part I of the Act applies only to raw opium, coca leaf and Indian hemp (and its resins), so a fungus is not reached through Part I. The word 'mushroom' and the word 'fungi' appear in none of the Acts. Psilocin is not a named substance, and whether psilocybin is an ester of a named substance is not stated by any instrument read, so paragraph 3 (which reaches an ester of a substance named in paragraph 1) is not treated as reaching it or as excluding it; this reading is outside the instruments and no verdict rests on it. The control model for dangerous drugs is delegated. Section 2 of the Dangerous Drugs Act defines a dangerous drug as 'any of the substances which may be from time to time subject to the provisions of this Act', and section 13(2) lets the Minister by proclamation apply Part III to further drugs. That power has been exercised (LN 101 of 1987, LN 6 of 1988, and the 2025 Rules made under section 15 and those two proclamations). The reprint carries no line closing its subsidiary legislation, and proclamations or rules made after the 1996 edition, other than the 2025 Rules, were not located. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament; it was not read, and a Bill is not law. Absence from the instruments read is therefore not a finding that psilocybin is uncontrolled, legal or unregulated, and no verdict is given. Not established: whether any instrument not read names the compound or the mushrooms that contain it.
Confirm directly with Solomon Islands’s national drug authority or your own embassy before you rely on anything.
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
